Observational Study Looking at the Testing of Alzheimer's Disease.

What we are studying

This study will look at the relationship between clinical, cognitive, imaging, genetic and biomarker tests in order to understand the full spectrum of Alzheimer’s disease (AD) from its earliest stages.

Who is Eligible

• Genders:
  • Men
  • Women
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 55 - 90

Eligibility Criteria

• Geriatric Depression Scale less than 6
• Study Partner
• Modified Hachinski less than or equal to 4
• Competed six grades of education.

What is involved

• 3 clinic visits
• 2 MRI
• 3 PET Scans
• 2 ECG
• 2 Lumbar Punctures
• Annual Phone Checks

Compensation

Clinic visit with study questionnaires, lab collection, vitals, medications, adverse events $50.00 Computer memory testing $10.00 MRI $25.00 FDG PET $50.00 Lumbar puncture $100.00 Amyloid PET $50.00 Tau PET $50.00 ECG $10.00

Contact Information

Study Coordinator

Tim Collare

Email

rcollare@wakehealth.edu

Phone

336-713-8825

Principal Investigator

Dr. Kaycee Sink